Clinical Trial Update: Targeted Clinical Strategies and Low Level Viraemia (LLV) in Boosted Protease Inhibitor Therapy

View source ↗

Summary

This clinical trial update discusses approaches to address low-level viraemia in patients on boosted protease inhibitor therapy for HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV | Status: UNKNOWN